broncho dilators

18
BRONCODILATORS Dr. Naila

Upload: affan-ahmad

Post on 23-Apr-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Broncho Dilators

BRONCODILATORSDr. Naila

Page 2: Broncho Dilators

Asthma is characterized Clinically

Physiologically

Pathologically

Page 3: Broncho Dilators

Pathogenesis of Asthma Exposure to allergen Synthesis of IgE Binding to mast cells in airway mucosa On reexposure to allergen, antigen-antibody

interaction on mast cell surface Release of mediators of anaphylaxis: histamine,

tryptase. PGD2, LTC4, PAF Contraction of airway smooth muscle-early

asthmatic response

Page 4: Broncho Dilators

Pathogenesis of Asthma (contd.) Cytokines Interleukins Eosinophils Neutrophils Late asthmatic response

Page 5: Broncho Dilators

REVERSAL OF ASTHMATIC BRONCHOSPASM

1. Drugs reducing amount of IgE bound to mast cells (Anti-IgE antibody)

2. Prevent mast cell degranulation (Cromolyn or Nedocromil)

3. Sympathomimetic agents4. Calcium channel blockers5. Block the action of the products released

(Antihistamines & leukotriene-receptor antagonists)6. Inhibit the release of acetylcholine released from vagal

motor nerves (muscarinic antagonists)7. Directly relax airway smooth muscle (sympathomimetic

agents, theophylline)

Page 6: Broncho Dilators

REDUCING BRONCHIAL RESPONSIVENESS

Corticosteroids- inhaled

Page 7: Broncho Dilators

Drug treatment of asthma

Relievers or Bronchodilators

Controllers or Anti-inflammatory agents

Page 8: Broncho Dilators

BRONCHODILATORS Sympathomimetic Agents

Rapid acting Short acting Long acting

Methylxanthine Drugs Theophylline Theobromine Caffeine

Antimuscarinic Agents Ipratropium bromide Tiotropium

Page 9: Broncho Dilators

SYMPATHOMIMETIC AGENTS Adrenoceptors agonists have several

pharmacologic actions that are important in the treatment of asthma

Relax airway smooth muscle Inhibit release of bronchoconstricting mediators

from mast cells Inhibit microvascular leakage Increase mucociliary transport

Page 10: Broncho Dilators

Mechanism Activate adenylyl cyclase via G-protein

Increase formation of intracellular cAMP

Page 11: Broncho Dilators

NON-SELECTIVE DRUGS Epinephrine Ephedrine Isoproterenolβ2- SELECTIVE DRUGS Albuterol Terbutaline Metaproterenol Pirbuterol Salmeterol long acting Formoterol

Page 12: Broncho Dilators

Toxicities of Sympathomimetic AgentsACUTE Cardiac arrhythmias HypoxemiaCHRONIC Tachyphylaxis Tolerance

Page 13: Broncho Dilators

METHYLXANTHINES Theophylline - Aminophylline Theobromine Caffeine

CHEMISTRY Methylated xanthine derivatives

Page 14: Broncho Dilators

Mechanism of ActionInhibit Phosphodiesterase Enzyme-PDE4 Higher concentrations of intracellular cyclic AMP Reduces release of cytokines and chemokines Resulting in decrease in immune cell migration &

activationInhibit cell-surface receptors for AdenosineEnhancement of Histone Deacetylation

Page 15: Broncho Dilators

Pharmacodynamics of Methylxanthines CNS effects CVS effects GIT effects Effect on the Kidneys Effects on Smooth Muscle Effects on Skeletal Muscle

Page 16: Broncho Dilators

Clinical Use of Methylxanthines Theophylline most effective Improves long term control of asthma Sustained release preparations Narrow therapeutic index Plasma clearance varies widely Inexpensive 3-4mg/kg every 6hrs

Page 17: Broncho Dilators

ANTIMUSCARINIC AGENTS Atropine Ipratropium bromide Tiotropium

MECHANISM Competitively inhibit the effect of

acetylcholine at muscarinic receptors

Page 18: Broncho Dilators

Clinical Use of Muscarinic Antagonists Effective bronchodilation Less effective than beta agonists Ipratropium - selective quaternary

ammonium compound

Tiotropium - longer acting, selective Inhalation 24 hour duration